Polymeric nanoparticles as a vehicle for delivery of antioxidants in the brain: Potential application in neurodegenerative diseases

Archive ouverte

Rabanel, Jean-Michel | Djiokeng Paka, Ghislain | Ramassamy, Charles

Edité par CCSD ; CRC Press -

International audience. The deleterious effect of oxidative stress in some neurodegenerative disorders (NDDs) such as Alzheimer's disease (AD) or Parkinson's diseases (PD) is well established. For instance, lipid peroxidation, protein oxidation, and nucleic acid oxidation damage markers were found to be elevated while antioxidant levels decreased in vulnerable region of the brain from patients with NDDs. However, curcumin brain bioavailability is low due to its low stability in solution and its poor permeability across the blood–brain barrier (BBB). In comparison with peripheral capillaries, the brain capillaries do not have fenestrations and microvessel endothelial cells (MECs) are recovered by pericytes and which confer a more tightly structure. The BBB is characterized by the presence of tight junctions (TJs) between MECs which induce a high transendothelial electrical restriction. TJs are the most important element in the junctional complex which is formed by transmembranar proteins such as claudins, a protein associated to the regulation of the microenvironment and in the control of cell proliferation.

Consulter en ligne

Suggestions

Du même auteur

Overcoming the Brain Barriers: From Immune Cells to Nanoparticles

Archive ouverte | Charabati, Marc | CCSD

International audience. Nanoparticulate carriers, often referred to as nanoparticles (NPs), represent an important pharmacological advance for drug protection and tissue-specific drug delivery. Accessing the central...

Periphery-confined particulate systems for the management of neurodegenerative diseases and toxicity: Avoiding the blood-brain-barrier challenge

Archive ouverte | Rabanel, Jean-Michel | CCSD

International audience. The blood-brain barrier prevents passage of large and hydrophilic molecules, undermining efforts to deliver most active molecules, proteins and other macromolecules. To date, nanoparticle-ass...

Transport of PEGylated-PLA nanoparticles across a blood brain barrier model, entry into neuronal cells and in vivo brain bioavailability

Archive ouverte | Rabanel, Jean-Michel | CCSD

International audience. Treatments of neurodegenerative diseases (NDDs) are severely hampered by the presence of the blood-brain barrier (BBB) precluding efficient brain drug delivery. The development of drug nanoca...

Chargement des enrichissements...